Niconovum Ab is a leading pharmaceutical company focused on developing innovative nicotine replacement therapies to help people quit smoking. Their products are designed to provide effective and convenient alternatives to traditional nicotine products, helping individuals break the cycle of addiction and improve their overall health and well-being.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

8 Patents

#14 in Helsingborg

#717 in Sweden

Helsingborg, Sweden

Niconovum Ab

Forward Citations = 203

8 inventors:

Henri Hansson (2 out of 18 patents)

Arne Kristensen (2 out of 9 patents)

Timothy James Llewellyn (2 out of 4 patents)

4. Dominic Peter Hale (2 out of 9 patents)

5. Timothy Rayner (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Niconovum Ab. Retrieved from https://idiyas.com/company/niconovum-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

6 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]